Yilmaz Ozyazgan

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusion.

Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusion.

Journal: Indian journal of ophthalmology

Published: August 23, 2020

An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults.

An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults.

Journal: Ocular immunology and inflammation

Published: April 15, 2020

Biosimilar infliximab for Behçet's syndrome: a case series.

Biosimilar infliximab for Behçet's syndrome: a case series.

Journal: Clinical and experimental rheumatology

Published: July 18, 2019

Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):: The Phase 2 SATURN Study.

Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):: The Phase 2 SATURN Study.

Journal: Ophthalmology

Published: February 16, 2018

Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Journal: Clinical and experimental rheumatology

Published: June 13, 2017

Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility.

Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility.

Journal: Nature genetics

Published: September 12, 2016

Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.

Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.

Journal: Genes and immunity

Published: May 13, 2016

Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.

Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.

Journal: Ocular immunology and inflammation

Published: February 02, 2016

A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.

A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.

Journal: Annals of the rheumatic diseases

Published: December 18, 2015

Temperament and Character Traits in Patients with Behçet's Disease with/without Eye Involvement.

Temperament and Character Traits in Patients with Behçet's Disease with/without Eye Involvement.

Journal: Seminars in ophthalmology

Published: August 21, 2015

Retinal nerve fiber layer structure abnormalities in patients with Neuro-Behcet's disease.

Retinal nerve fiber layer structure abnormalities in patients with Neuro-Behcet's disease.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: February 13, 2015

Interferon alfa-associated depression in patients with Behçet's syndrome: a prospective controlled study.

Interferon alfa-associated depression in patients with Behçet's syndrome: a prospective controlled study.

Journal: Clinical and experimental rheumatology

Published: June 13, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026